Plunkett Research Online: pSivida Corp

PSIVIDA CORP (PSDV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

PSivida Corp. develops sustained-release drug delivery products primarily for the treatment of chronic eye diseases. The firm’s products deliver drugs at a controlled and steady rate for months or years. pSivida has developed three sustained-release approved by the U.S. Food and Drug Administratio.....



pSivida Corp
Ticker: PSDV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 926-5000
Fax: 617 926-5050
Address: 480 Pleasant Street
Watertown, MA 02472 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Biotechnology Research
Nanostructured Silicon
Drug Delivery Technology
ContactsDescription
Leonard RossCFO/Chief Accounting Officer/Vice President, Divisional
David MazzoChairman of the Board/Director
See More
PSivida Corp. develops sustained-release drug delivery products primarily for the treatment of chronic eye diseases. The firm’s products deliver drugs at a controlled and steady rate for months or years. pSivida has developed three sustained-release approved by the U.S. Food and Drug Administratio.....See More See More

Auditor: Deloitte & Touche LLP
Legal Advisor: Ropes & Gray LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Medidur
ILUVIEN
Retisert
Duraset
Tethadur
Vitrasert
ILUVIEN
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: